{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:39:17Z","timestamp":1785137957456,"version":"3.55.0"},"reference-count":53,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Shigellosis represents a significant global health concern particularly affecting children under 5 years in low- and middle-income countries (LMICs) and is associated with stunting and antimicrobial resistance. There is a critical need for an effective vaccine offering broad protection against the different Shigella serotypes. A correlate of protection has not yet been established but there is a general consensus about the relevant role of anti-O-Antigen-specific IgG and its functionality evaluated by the Serum Bactericidal Assay (SBA). This study aims to characterize a high-throughput luminescence-based SBA (L-SBA) against seven widespread Shigella serotypes. The assay was previously developed and characterized for S. sonnei and S. flexneri 1b, 2a, and 3a and has now been refined and extended to an additional five serotypes (S. flexneri 4a, 5b, 6, X, and Y). The characterization of the assay with human sera confirmed the repeatability, intermediate precision, and linearity of the assays; both homologous and heterologous specificity were verified as well; finally, limit of detection and quantification were established for all assays. Moreover, different sources of baby rabbit complement showed to have no impact on L-SBA output. The results obtained confirm the possibility of extending the L-SBA to multiple Shigella serotypes, thus enabling analysis of the functional response induced by natural exposure to Shigella in epidemiological studies and the ability of candidate vaccines to elicit cross-functional antibodies able to kill a broad panel of prevalent Shigella serotypes in a complement-mediated fashion.<\/jats:p>","DOI":"10.3390\/ijms252011123","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T11:28:51Z","timestamp":1729078131000},"page":"11123","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High-Throughput Luminescence-Based Serum Bactericidal Assay Optimization and Characterization to Assess Human Sera Functionality Against Multiple Shigella flexneri Serotypes"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3092-125X","authenticated-orcid":false,"given":"Valentina","family":"Caradonna","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy"},{"name":"GSK Vaccines Institute for Global Health (GVGH), 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pinto","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health (GVGH), 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7103-0723","authenticated-orcid":false,"given":"Renzo","family":"Alfini","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health (GVGH), 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6112-6841","authenticated-orcid":false,"given":"Carlo","family":"Giannelli","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health (GVGH), 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Iturriza","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health (GVGH), 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Micoli","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health (GVGH), 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0170-1285","authenticated-orcid":false,"given":"Omar","family":"Rossi","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health (GVGH), 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2122-9480","authenticated-orcid":false,"given":"Francesca","family":"Mancini","sequence":"additional","affiliation":[{"name":"GSK Vaccines Institute for Global Health (GVGH), 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e919","DOI":"10.1016\/S2214-109X(24)00078-0","article-title":"Estimated global and regional causes of deaths from diarrhoea in children younger than 5 years during 2000\u201321: A systematic review and Bayesian multinomial analysis","volume":"12","author":"Black","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-28121-1","article-title":"Population structure analysis and laboratory monitoring of Shigella by core-genome multilocus sequence typing","volume":"13","author":"Yassine","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.5001\/omj.2023.65","article-title":"Shigella flexneri Serotypes: O-antigen Structure, Serotype Conversion, and Serotyping Methods","volume":"38","author":"Sadredinamin","year":"2023","journal-title":"Oman Med. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","article-title":"Shigellosis","volume":"391","author":"Kotloff","year":"2018","journal-title":"Lancet"},{"key":"ref_5","first-page":"81","article-title":"Shigella: A Highly Virulent and Elusive Pathogen","volume":"1","author":"Zaidi","year":"2014","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.vaccine.2022.12.037","article-title":"Vaccine value profile for Shigella","volume":"41","author":"Hausdorff","year":"2023","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/S2214-109X(18)30045-7","article-title":"Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years","volume":"6","author":"Troeger","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijid.2023.01.034","article-title":"Consequences of Shigella infection in young children: A systematic review","volume":"129","author":"Libby","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/cid\/ciac969","article-title":"Shigella in Africa: New Insights from the Vaccine Impact on Diarrhea in Africa (VIDA) Study","volume":"76","author":"Kasumba","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bagamian, K.H., Iv, J.D.A., Blohm, G., and Scheele, S. (2023). Shigella and childhood stunting: Evidence, gaps, and future research directions. PLOS Neglected Trop. Dis., 17.","DOI":"10.1371\/journal.pntd.0011475"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000\u201315: An updated systematic analysis with implications for the Sustainable Development Goals","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1473-3099(18)30475-4","article-title":"Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: The Global Burden of Disease Study 1990\u20132016","volume":"18","author":"Khalil","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Salleh, M.Z., Zuraina, N.M.N.N., Hajissa, K., Ilias, M.I., Singh, K.K.B., and Deris, Z.Z. (2022). Prevalence of Multidrug-Resistant and Extended-Spectrum Beta-Lactamase-Producing Shigella Species in Asia: A Systematic Review and Meta-Analysis. Antibiotics, 11.","DOI":"10.3390\/antibiotics11111653"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Phiri, A.F., Abia, A.L.K., Amoako, D.G., Mkakosya, R., Sundsfjord, A., Essack, S.Y., and Simonsen, G.S. (2021). Burden, Antibiotic Resistance, and Clonality of Shigella spp. Implicated in Community-Acquired Acute Diarrhoea in Lilongwe, Malawi. Trop. Med. Infect. Dis., 6.","DOI":"10.3390\/tropicalmed6020063"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1017\/S0950268804003048","article-title":"Genetic analysis of antibiotic-resistance determinants in multidrug-resistant Shigella strains isolated from Chilean children","volume":"133","author":"Toro","year":"2004","journal-title":"Epidemiol. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3201\/eid1907.121221","article-title":"Multidrug-Resistant Atypical Variants of Shigella flexneri in China","volume":"19","author":"Qiu","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_17","first-page":"1","article-title":"Rapid emergence of extensively drug-resistant Shigella sonnei in France","volume":"14","author":"Njamkepo","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3201\/eid2806.220131","article-title":"Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017\u20132020","volume":"28","author":"Gaufin","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S1473-3099(22)00807-6","article-title":"Emergence of extensively drug-resistant and multidrug-resistant Shigella flexneri serotype 2a associated with sexual transmission among gay, bisexual, and other men who have sex with men, in England: A descriptive epidemiological study","volume":"23","author":"Thorley","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S1473-3099(17)30467-X","article-title":"Antimicrobial resistance among children in sub-Saharan Africa","volume":"18","author":"Williams","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2280838","DOI":"10.1080\/21505594.2023.2280838","article-title":"Pathogenicity and virulence of Shigella sonnei: A highly drug-resistant pathogen of increasing prevalence","volume":"14","author":"Matanza","year":"2023","journal-title":"Virulence"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12223-020-00773-w","article-title":"Shigella flexneri: An emerging pathogen","volume":"65","author":"Nisa","year":"2020","journal-title":"Folia Microbiol."},{"key":"ref_23","first-page":"901","article-title":"O-Antigen modifications providing antigenic diversity of Shigella flexneri and underlying genetic mechanisms","volume":"80","author":"Knirel","year":"2015","journal-title":"Biochemistry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/21645515.2019.1606971","article-title":"Serum IgG antibodies to Shigella lipopolysaccharide antigens\u2014A correlate of protection against shigellosis","volume":"15","author":"Cohen","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41541-024-00822-2","article-title":"Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine","volume":"9","author":"Conti","year":"2024","journal-title":"npj Vaccines"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cmi.2022.10.011","article-title":"Threshold protective levels of serum IgG to Shigella lipopolysaccharide: Re-analysis of Shigella vaccine trials data","volume":"29","author":"Cohen","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/cid\/ciu468","article-title":"Shigella Isolates from the Global Enteric Multicenter Study Inform Vaccine Development","volume":"59","author":"Livio","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","unstructured":"World Health Organization (2021). WHO Preferred Product Characteristics for Vaccines Against Shigella, World Health Organization."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/IAI.67.2.782-788.1999","article-title":"Strategy for Cross-Protection Among Shigella flexneri Serotypes","volume":"67","author":"Noriega","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0264-410X(96)00006-0","article-title":"Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection","volume":"14","author":"Bendiuk","year":"1996","journal-title":"Vaccine"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"MacLennan, C.A., Grow, S., Ma, L.-F., and Steele, A.D. (2022). The Shigella Vaccines Pipeline. Vaccines, 10.","DOI":"10.3390\/vaccines10091376"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41541-023-00725-8","article-title":"A next-generation GMMA-based vaccine candidate to fight shigellosis","volume":"8","author":"Rossi","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Mancini, F., Alfini, R., Caradonna, V., Monaci, V., Carducci, M., Gasperini, G., Piccioli, D., Biagini, M., Giannelli, C., and Rossi, O. (2023). Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against Shigella. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032742"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Micoli, F., Nakakana, U.N., and Scorza, F.B. (2022). Towards a Four-Component GMMA-Based Vaccine against Shigella. Vaccines, 10.","DOI":"10.3390\/vaccines10020328"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Leroux-Roels, I., Maes, C., Mancini, F., Jacobs, B., Sarakinou, E., Alhatemi, A., Joye, J., Grappi, S., Cilio, G.L., and Serry-Bangura, A. (2024). Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1\/2 Study. J. Infect. Dis., jiae273.","DOI":"10.1093\/infdis\/jiae273"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Martin, P., and Alaimo, C. (2022). The Ongoing Journey of a Shigella Bioconjugate Vaccine. Vaccines, 10.","DOI":"10.3390\/vaccines10020212"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mo, Y., Fang, W., Li, H., Chen, J., Hu, X., Wang, B., Feng, Z., Shi, H., He, Y., and Huang, D. (2021). Safety and Immunogenicity of a Shigella Bivalent Conjugate Vaccine (ZF0901) in 3-Month- to 5-Year-Old Children in China. Vaccines, 10.","DOI":"10.3390\/vaccines10010033"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41541-023-00624-y","article-title":"A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults","volume":"8","author":"Asato","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.vaccine.2015.07.019","article-title":"Serum bactericidal antibody assays\u2014The role of complement in infection and immunity","volume":"33","author":"McIntosh","year":"2015","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","article-title":"Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease","volume":"27","author":"Frasch","year":"2009","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Boero, E., Vezzani, G., Micoli, F., Pizza, M., and Rossi, O. (2023). Functional assays to evaluate antibody-mediated responses against Shigella: A review. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1171213"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S596","DOI":"10.1093\/cid\/ciz909","article-title":"Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays","volume":"69","author":"Kaminski","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kapulu, M.C., Nakakana, U., Scir\u00e9, A.S., Sarakinou, E., Conti, V., Rossi, O., Acquaviva, A., Necchi, F., Obiero, C.W., and Martin, L.B. (2022). Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.971866"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Micoli, F., Rossi, O., Conti, V., Launay, O., Scir\u00e9, A.S., Aruta, M.G., Nakakana, U.N., Marchetti, E., Rappuoli, R., and Saul, A. (2021). Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results from a Phase 1 Dose Escalation Trial Followed by a Booster Extension. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.671325"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Citiulo, F., Necchi, F., Mancini, F., Rossi, O., Aruta, M.G., Gasperini, G., Alfini, R., Rondini, S., Micoli, F., and Rappuoli, R. (2021). Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes. PLOS Neglected Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009826"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mancini, F., Micoli, F., and Rossi, O. (2022). Setup and Characterization of a High-Throughput Luminescence-Based Serum Bactericidal Assay (L-SBA) to Determine Functionality of Human Sera against Shigella flexneri. BioTech, 11.","DOI":"10.3390\/biotech11030029"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4939-9496-0_16","article-title":"Complement-dependent serum bactericidal assays for Neisseria gonorrhoeae","volume":"Volume 1997","author":"Gulati","year":"2019","journal-title":"Neisseria gonorrhoeae: Methods and Protocols"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-021-00286-8","article-title":"Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B","volume":"6","author":"Kleinschmidt","year":"2021","journal-title":"npj Vaccines"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1016\/j.vaccine.2014.08.010","article-title":"Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection","volume":"32","author":"Townsend","year":"2014","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Necchi, F., Saul, A., and Rondini, S. (2017). Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0172163"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Gerke, C., Colucci, A.M., Giannelli, C., Sanzone, S., Vitali, C.G., Sollai, L., Rossi, O., Martin, L.B., Auerbach, J., and Di Cioccio, V. (2015). Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134478"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Rossi, O., Molesti, E., Saul, A., Giannelli, C., Micoli, F., and Necchi, F. (2020). Intra-Laboratory Evaluation of Luminescence Based High-Throughput Serum Bactericidal Assay (L-SBA) to Determine Bactericidal Activity of Human Sera against Shigella. BioTech, 9.","DOI":"10.1101\/2020.04.03.024950"},{"key":"ref_53","unstructured":"The International Council for Harmonisation (2022). ICH Harmonized Guideline, Validation of Analytical Procedures, Q2(R2), ICH."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/20\/11123\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:14:39Z","timestamp":1760112879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/20\/11123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":53,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["ijms252011123"],"URL":"https:\/\/doi.org\/10.3390\/ijms252011123","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]}}}